Literature DB >> 19348965

Effect of imbalance and intracluster correlation coefficient in cluster randomization trials with binary outcomes when the available number of clusters is fixed in advance.

Chul Ahn1, Fan Hu, Celette Sugg Skinner, Daniel Ahn.   

Abstract

In some cluster randomization trials, the number of clusters cannot exceed a specified maximum value due to cost constraints or other practical reasons. Donner and Klar [Donner A, and Klar N. Design and analysis of cluster randomization trials in health research. Oxford University Press 2000] provided the sample size formula for the number of subjects required per cluster when the number of clusters cannot exceed a specified maximum value. The sample size formula of Donner and Klar assumes that the number of subjects is the same in each cluster. In practical situations, the number of subjects may be different among clusters. We conducted simulation studies to investigate the effect of the cluster size variability (kappa) and the intracluster correlation coefficient (rho) on the power of the study in which the number of available clusters is fixed in advance. For the balanced case (kappa=1.0), i.e., equal cluster size among clusters, the sample size formula yielded empirical powers close to the nominal level even when the number of available clusters per group (k*) is as small as 10. The sample size formula yielded empirical powers close to the nominal level when the number of available clusters per group (k*) is at least 20 and the imbalance parameter (kappa) is at least 0.8. Empirical powers were close to the nominal level when (rho< or =0.02, kappa> or =0.8, and k*=10) or (rho< or =0.02, kappa=0.8, and k*=20).

Entities:  

Mesh:

Year:  2009        PMID: 19348965      PMCID: PMC2716697          DOI: 10.1016/j.cct.2009.03.007

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  4 in total

Review 1.  Methodology for inferences concerning familial correlations: a review.

Authors:  A Donner; M Eliasziw
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

Review 2.  Patterns of intra-cluster correlation from primary care research to inform study design and analysis.

Authors:  Geoffrey Adams; Martin C Gulliford; Obioha C Ukoumunne; Sandra Eldridge; Susan Chinn; Michael J Campbell
Journal:  J Clin Epidemiol       Date:  2004-08       Impact factor: 6.437

3.  Accounting for expected attrition in the planning of community intervention trials.

Authors:  Monica Taljaard; Allan Donner; Neil Klar
Journal:  Stat Med       Date:  2007-06-15       Impact factor: 2.373

4.  Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.

Authors:  Celette Sugg Skinner; Susan M Rawl; Barry K Moser; Adam H Buchanan; Linda L Scott; Victoria L Champion; Joellen M Schildkraut; Giovanni Parmigiani; Shelly Clark; David F Lobach; Lori A Bastian
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

  4 in total
  2 in total

Review 1.  Review of Recent Methodological Developments in Group-Randomized Trials: Part 1-Design.

Authors:  Elizabeth L Turner; Fan Li; John A Gallis; Melanie Prague; David M Murray
Journal:  Am J Public Health       Date:  2017-04-20       Impact factor: 9.308

2.  Culturally tailored, peer-based sleep health education and social support to increase obstructive sleep apnea assessment and treatment adherence among a community sample of blacks: study protocol for a randomized controlled trial.

Authors:  Azizi A Seixas; Chau Trinh-Shevrin; Joseph Ravenell; Gbenga Ogedegbe; Ferdinand Zizi; Girardin Jean-Louis
Journal:  Trials       Date:  2018-09-24       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.